Mississippi hearing spotlights public-health risks of intoxicating hemp; stakeholders push testing, age limits and beverage caps

The Public Health and Welfare committee heard two hours of testimony on the public‑health implications of intoxicating hemp products, with state health officials and researchers urging rules to require product testing, eliminate synthetic cannabinoids and restrict sales to adults.

Dr. Robert Welch of the National Center for Cannabis Research at the University of Mississippi told the committee that many retail hemp products sold across the state are variable, sometimes adulterated and occasionally highly intoxicating. “Just because industrial hemp is legal doesn't mean it can be put into food or called medicine,” he quoted former FDA Commissioner Scott Gottlieb, and he described testing his team and law enforcement carried out: of 25 retail CBD products seized and analyzed, 22 had measurable CBD, concentrations ranged from 0.02 milligrams to 786 milligrams, only three matched label claims within 20 percent, three exceeded the 0.3 percent delta‑9 THC threshold and one sample measured about 45 percent THC. He also said four products were adulterated with synthetic cannabinoids and that many delta‑8 and related products are synthesized rather than plant‑derived.

State Health Officer Dr. Edney told the committee the Department of Health is not the bill sponsor but is prepared to help craft language. “We have a problem, and we certainly will take any assignment that you think will be helpful to help solve the problem,” he said. Edney emphasized a recurring testing gap: harvest‑time testing based on dry weight can miss transformations that occur before finished products reach consumers.

Committee members and stakeholders debated several regulatory approaches that appeared repeatedly in testimony: require testing of finished products at point of sale, treat intoxicating hemp beverages like beer with licensing and a single‑serving milligram cap, ban synthetic cannabinoids such as delta‑8/delta‑10, and enforce age gating for retail sales.

Representative and former Senator Lee Yancey urged a testing‑based bright line: test finished products and allow sale only when delta‑9 THC is 0.3 percent or less by the finished form. “Let's test them. Let's make this a testing issue and look at the 3 tenths percent THC line of demarcation set forth by the 2018 farm bill,” Yancey said.

Retail and distributor groups said they support regulation but urged clarity so legitimate, federally legal hemp businesses are not unintentionally banned. Philip Chamblee of the Mississippi Petroleum Marketers and Convenience Store Association said his members want to “sell legal products responsibly” and support age gating and labeling review. Ricky Brown of the Mississippi Beer Distributors Association proposed treating intoxicating hemp beverages like beer, with a single‑serving cap: “put a cap of 5 milligrams per container and can only be sold in a 12 ounce container,” he said, and suggested licensing and distribution through existing beer channels.

Mississippi Small Business Coalition executive Emmanuel Williams and retail owner Bill Wikstrom argued for measured regulation that preserves federally legal hemp businesses while protecting children and consumers. Retailers said they generally require certificates of analysis from manufacturers and check IDs, but acknowledged third‑party testing by Steep Hill Labs and others has found many retail samples failing independent analyses; committee testimony noted recent testing in which multiple samples failed heavy‑metals, pesticide or potency checks.

Public‑health data cited during the hearing included national CDC trends and Poison Control Center case calls showing a rise in accidental pediatric exposures after the 2018 Farm Bill. Welch and Edney said children and adolescents account for a majority of reported edible exposures in the available Poison Control data and that a significant share of major clinical adverse events were in early‑adolescent patients.

The committee did not vote on substantive legislation during the hearing. Members received copies of House Bill 1502 as introduced and a proposed Senate “strike‑all” substitute (Senate Bill 2706 was discussed as a draft counterpart). Chairman (unnamed in transcript) said the bill is “doubly referred to finance” and that staff provided a side‑by‑side analysis; the committee intends to consider the measure further and may seek refinements before forwarding it to the Finance Committee.

The hearing closed after a procedural motion to rise and report passed by voice vote.

Outlook: witnesses and lawmakers converged on several policy tools — finished‑product testing, clearer enforcement authority, age restrictions, labeling/packaging limits to avoid child‑appealing designs, prohibition of synthetic intoxicants and a possible milligram cap for beverage servings — but differed on the scope and mechanics. Committee staff provided comparative drafts to members for follow‑up work.